Correlation Between Blueprint Medicines and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Blueprint Medicines and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Zentalis Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Zentalis Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Zentalis is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.44 times more return on investment than Zentalis Pharmaceuticals. However, Blueprint Medicines Corp is 2.25 times less risky than Zentalis Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.08 per unit of risk. If you would invest 7,420 in Blueprint Medicines Corp on November 3, 2024 and sell it today you would earn a total of 3,833 from holding Blueprint Medicines Corp or generate 51.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Zentalis Pharmaceuticals |
Blueprint Medicines and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Zentalis Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |